Heterologous vaccine

Source: Wikipedia, the free encyclopedia.

Vaccination regimes where a second, booster vaccination takes place with a different type of vaccine than the first vaccination are called heterologous.[1][2]

References

  1. ^ Shaw, Robert H.; Stuart, Arabella; Greenland, Melanie; Liu, Xinxue; Van-Tam, Jonathan S. Nguyen; Snape, Matthew D. (29 May 2021). "Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data". The Lancet. 397 (10289): 2043–2046. doi:10.1016/S0140-6736(21)01115-6. PMC 8115940. PMID 33991480.
  2. ^ Ho SY, Chua SQ, Foo DG, et al. (January 2008). "Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates". Infect. Immun. 76 (1): 111–9. doi:10.1128/IAI.00795-07. PMC 2223651. PMID 17954727.
This page is based on the copyrighted Wikipedia article: Heterologous vaccine. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.